Cholesterol Therapy

Tim Mayleben Named President And CEO Of Esperion TherapeuticsEsperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, announced that Tim Mayleben has been named president and CEO of the company.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen